People · Operator
Named in public records as an officer, director or promoter · active 2013–2022 · Biotech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Watchmaker Genomics, Inc. | — | Biotech | Series B | $48.3M | $712.8M | 2020 |
| Enzymatics Inc | — | Other | Seed | $3.8M | $70.4M | 2013 |
Stephen Picone at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Picone on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Manning | 1 | 6 |
| Ian Ratcliffe | 1 | 6 |
| Victor Tong | 1 | 6 |
| Christopher McGuinness | 1 | 3 |
| Christopher Benoit | 1 | 3 |
| Paul McEwan | 1 | 3 |
| John Foskett | 1 | 1 |
| Brian Kudlow | 1 | 1 |
| Brian Deneau | 1 | 1 |
| Jack Percoskie | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.